Opportunity, I don't care if you agree with me or not. I am just stating the facts that it appears that Moro has changed his mind about taking RECAF into clinical trials on his own.
Read the quote below. It is new wording by Moro and not just a cut and paste from earlier filings. It says absolutely NOTHING about the company getting a RECAF product FDA approved. However, it does now clearly state that the partners or licensees would do the regulatory functions.
I am just agreeing with Moro that it is probably a more cost effective use of his current cash.
From the 10Q filed August 15, 2010:
"Our business model is to develop internally our RECAF cancer diagnostic
platform to the stage where individual applications can be partnered or licensed
in strategic relationships for regulatory approval and commercialization.
Our
objective is to receive cash from licensing fees, milestone payments, and
royalties from such partnerships which support continued development of our
cancer diagnostic portfolio. We have signed licensing agreements for its cancer
detection blood tests with Abbott Laboratories and with Inverness Medical
Innovations. In the veterinarian market where there are no regulatory hurdles,
our objective is to commercialize our technology through our subsidiary, OncoPet
Diagnostics, and with distributors in North America, Europe and elsewhere.
Our principal objectives for the twelve-month period ending June 30, 2011
are as follows:
o grant one additional license for our cancer detection blood test;
o commercialize veterinary applications of RECAF testing technology through our wholly-owned subsidiary, OncoPet Diagnostics;
o finish development for our rapid, point of care cancer test; and
GoldSeeker™
I have never shorted nor intend to have any financial interest in BOCX. I am not connected with anyone who trades, shorts or has financial interests in BOCX. I only post facts and my opinions. I do not post on IHUB with different aliases.
AI
